TiO₂ Nanoparticle Development Service for Enhanced Sonosensitizer Delivery
TiO₂ Nanoparticles: Revolutionizing Sonodynamic Therapy for Enhanced Cancer Treatment
Creative Biolabs' TiO₂ nanoparticle development service enhances sonosensitizer delivery, overcoming limitations of traditional cancer therapies like poor light penetration in photodynamic therapy. We engineer advanced titanium dioxide (TiO₂) nanoparticles as efficient sonosensitizers, generating potent reactive oxygen species upon ultrasound activation to destroy cancer cells and disrupt tumor vasculature. Our expertise in surface modification ensures enhanced systemic stability, prolonged circulation, and precise tumor accumulation via passive and active targeting. This approach, supported by published literature, demonstrates remarkable efficacy in suppressing tumor growth in both superficial and deep-seated tumors.
Why TiO₂ Nanoparticles are the Future of Sonosensitizers
Biocompatibility and Low Toxicity
TiO₂ NPs are generally considered non-toxic to mammalian cells under physiological conditions, making them ideal candidates for biomedical applications.
Chemical Inertness and Stability
Their inherent stability ensures integrity within the complex biological milieu, resisting degradation by biological enzymes or reactive oxygen species themselves.
Potent ROS Generation
TiO₂ NPs possess inherent photocatalytic properties, which can be effectively harnessed for sonocatalytic activity, leading to efficient reactive oxygen species generation upon ultrasound activation. This ROS generation can induce various cell death pathways, including apoptosis and ferroptosis, and can also modulate the immune response against tumors.
Workflow
Our streamlined workflow at Creative Biolabs ensures a collaborative and efficient development process, meticulously tailored to your specific research needs and therapeutic goals. Each stage is designed to provide clear outcomes, guiding your project from initial concept to robust preclinical validation.
Publication
This publication introduces a novel non-invasive sonodynamic therapy (SDT) for cancer using reactive oxygen species (ROS)-generating hydrophilized titanium dioxide nanoparticles (HTiO₂ NPs). Conventional photodynamic therapy (PDT) is limited by the poor tissue penetration of light, which is its energy source. In contrast, ultrasound (US) can penetrate much deeper into biological tissue and activate sensitizers to generate ROS. This study demonstrates the feasibility of using HTiO₂ NPs, activated by ultrasound, to effectively suppress the growth of both superficial and deeply located liver tumors in mice. The HTiO₂ NPs generate ROS, which leads to increased levels of proinflammatory cytokines and significant vascular damage within the tumor tissue. The researchers chose carboxymethyl dextran (CMD) as a hydrophilic polymer to coat the TiO₂ NPs, enhancing their stability and prolonging their systemic circulation, which contributes to their excellent tumor-homing abilities. This work provides the first in vivo demonstration of HTiO₂ NPs as sensitizers for sonodynamic therapy.
Fig.1 Surface engineering of TiO₂ nanoparticles.1
Why Choose Us?
Creative Biolabs is a premier partner for TiO₂ nanoparticle development, distinguished by unparalleled scientific expertise and cutting-edge technology. With nearly two decades in nanomedicine, our highly skilled team ensures optimal design. We offer advanced synthesis, characterization, and in vitro/in vivo testing platforms, allowing precise control and robust validation. Our customization, flexibility, and rigorous protocols guarantee the highest quality and efficacy. Supported by published data showing significant tumor suppression and enhanced ROS generation, we transform therapeutic pipelines with scientific rigor and support.
FAQs
Q1: How do your TiO₂ nanoparticles improve upon existing sonosensitizers?
A1: Our TiO₂ nanoparticles are engineered for enhanced stability and superior ROS generation upon ultrasound. Unlike conventional sonosensitizers, they're chemically inert and highly stable. Advanced surface modifications ensure precise tumor targeting and potent SDT.
Q2: Are there any specific precautions or considerations for handling and using your TiO₂ nanoparticles in experiments?
A2: Our TiO₂ nanoparticles are biocompatible and low-toxicity. We provide meticulous handling guidelines, storage conditions, and ultrasound parameters with your order. Our team offers in-depth technical support for optimal usage, ensuring maximum efficacy and safety.
Q3: What are the key advantages of using your service compared to developing TiO₂ nanoparticles in-house?
A3: Partner with Creative Biolabs for nearly 20 years of nanomedicine expertise, state-of-the-art facilities, and proprietary techniques. We offer accelerated development, rigorous quality control, and comprehensive characterization, saving you resources and fast-tracking your research.
Customer Review
-
Exceptional Stability in Biological Media
We were particularly impressed by the long-term stability of the TiO₂ NPs developed by Creative Biolabs in serum conditions. This was a critical factor for our systemic delivery applications, as aggregation had been a major hurdle with previous formulations. Their surface modification techniques truly made a difference in maintaining nanoparticle integrity and dispersibility. - Dr. S. La*ng
-
Tailored Solutions for Complex Projects
Our project involved a very specific and challenging nanoparticle design, but Creative Biolabs' team was incredibly adaptable. They listened to our unique requirements and delivered a customized TiO₂ formulation that perfectly met our needs. Their flexibility and problem-solving approach are truly exceptional, making them an invaluable partner. - Dr. E. F***er
Related Services
To further support your oncology research and therapeutic development, Creative Biolabs offers a comprehensive suite of complementary services and related product options. These offerings are designed to provide a holistic approach to your therapeutic goals.
Combination Therapy Development
Creative Biolabs excels in personalized cancer immune combination therapy, offering custom regimens tailored to genetic profiles, improving outcomes, and reducing recurrence.
Learn More →ADC Conjugation Service
With a decade of experience, Creative Biolabs offers comprehensive ADC discovery and development services, delivering promising antibody-drug conjugates to advance your therapeutic pipeline.
Learn More →How to Contact Us
Ready to advance your oncology research with next-generation TiO₂ nanoparticles? Our team of dedicated experts at Creative Biolabs is eager to discuss your specific project needs, answer any further questions, and provide tailored solutions to meet your scientific objectives.
Contact Our Team for More Information and to Discuss Your Project – Your Breakthrough Awaits!
Reference
- You, Dong Gil, et al. "ROS-generating TiO₂ nanoparticles for non-invasive sonodynamic therapy of cancer." Scientific reports 6.1 (2016): 23200. Distributed under Open Access license CC BY 4.0, without modification. DOI: https://doi.org/10.1038/srep23200
Download our brochure